Pre-reading questions:
I will read each question. Then, please answer them.
- How have partnerships played a role in historical breakthroughs or innovations?
- Why is it important to continually develop new treatments for various diseases?
Vocabulary:
I will read the words, meanings, and sample sentences. Then, repeat after me.
- partnership /PAHRT-ner-ship /
- treatment /TREET-muhnt/
- highlight /HAHY-lahyt/
- contribute /kuhn-TRIB-yoot/
- combined /kuhm-bahynd/
[noun] – an association or alliance between two or more parties for mutual benefit
The partnership between the two companies resulted in groundbreaking research.
[noun] – medical care given to a patient for an illness or injury
The new treatment shows promise for combating the disease.
[verb] – to emphasize or draw attention to something
The speaker used visuals to highlight the key points of the presentation.
[verb] – to give or add to a common purpose
Everyone can contribute to a cleaner environment by reducing their plastic usage.
[adjective] – joined or united to form a whole
The combined efforts of the team led to the project’s success.
Article reading:
Please read the whole article. Then, I will check your pronunciation and intonation.
In a recent development, Nona Biosciences has formed a partnership with Lycia Therapeutics, a prominent player in breaking down proteins outside cells. Lycia, known for its lysosomal targeting chimeras (LYTACs) platform, aims to discover and develop treatments that break down proteins associated with challenging diseases. Through this collaboration, Lycia will utilize Nona’s Harbour Mice® HCAb fully human antibody transgenic mice platform to identify new antibodies for its LYTAC protein degrader treatments. Dr. Jingsong Wang, Chairman of Nona Biosciences, anticipates that this collaboration will accelerate Lycia’s progress in creating innovative protein degrader treatments. Dr. Steve Staben, Chief Scientific Officer of Lycia Therapeutics, highlights the unique capabilities of LYTACs in addressing extracellular disease targets. The overarching goal of this partnership is to leverage Nona Biosciences’ technology to discover treatments for patient groups often overlooked in medical research.
Nona Biosciences, a global biotech company and a wholly-owned subsidiary of HBM Holdings Limited, provides comprehensive solutions for biotech innovation. From confirming targets to finding antibodies and conducting preclinical research, Nona Biosciences employs the Harbour Mice® technology, producing fully human monoclonal antibodies. Positioned globally, the company aims to contribute to the development of groundbreaking next-gen drugs. The collaboration between Nona Biosciences and Lycia Therapeutics marks a significant step in addressing challenging diseases globally. Their combined expertise and use of advanced technologies offer hope for effective treatments for underserved patient populations.
Nona Biosciences, a global biotech company and a wholly-owned subsidiary of HBM Holdings Limited, provides comprehensive solutions for biotech innovation. From confirming targets to finding antibodies and conducting preclinical research, Nona Biosciences employs the Harbour Mice® technology, producing fully human monoclonal antibodies. Positioned globally, the company aims to contribute to the development of groundbreaking next-gen drugs. The collaboration between Nona Biosciences and Lycia Therapeutics marks a significant step in addressing challenging diseases globally. Their combined expertise and use of advanced technologies offer hope for effective treatments for underserved patient populations.
Comprehension questions
I will read each question. Then, please answer them based on the article.
- What does the collaboration between Nona Biosciences and Lycia Therapeutics aim to achieve?
- How does Lycia Therapeutics plan to identify new antibodies for its LYTAC protein degrader treatments in collaboration with Nona Biosciences?
- According to Dr. Jingsong Wang, what is the anticipated impact of the collaboration between Nona Biosciences and Lycia Therapeutics?
- What is the overarching goal of the partnership between Nona Biosciences and Lycia Therapeutics?
- How does the article describe the expertise and use of advanced technologies of Nona Biosciences and Lycia Therapeutics in addressing challenging diseases globally?
Discussion questions
I will read each question. Then, please answer them.
- Have you ever worked on a project that required collaboration with others? If so, how did it contribute to the success of the project? If not, do you think collaboration could enhance the outcomes of a project?
- In your experience, do you believe that wholly committing to a task is essential for achieving success, or do you think partial efforts can also lead to positive results?
- Do you agree that collaboration is a crucial factor in advancing scientific research and finding innovative solutions to complex problems, as highlighted in the article?
- Considering the collaboration between Nona Biosciences and Lycia Therapeutics, how might this partnership influence the development of treatments for diseases that are often overlooked?
- In what ways do you think the integration of cutting-edge technologies, as mentioned in the article, could shape the future of biotech innovation and impact patient populations globally?